Pulmonary disposition and pharmacokinetics of minocycline in adult horses.

The research article discusses a study conducted to understand the pharmacokinetics and pulmonary disposition of minocycline in adult horses, after being administered intravenously (IV) and intragastrically. The article revealed that minocycline’s mean bioavailability was 48%.

Study Design and Objectives

• The primary objective of the study was to determine the pharmacokinetics (how the drug is absorbed, distributed, metabolized, and excreted in the body) and pulmonary disposition of minocycline in horses.
• The study was conducted in two experiments using seven healthy adult horses.
• In both experiments, minocycline was administered either intravenously (IV) or intragastrically (through the stomach), and various samples were then collected to evaluate the drug’s effects.

Experiment Procedures and Outcomes

• In the first experiment, minocycline was administered to six horses either IV (2.2 mg/kg) or intragastrically (4 mg/kg) using a randomized crossover design.
• Plasma samples were obtained before administration and 16 times within 36 hours after administration. Bronchoalveolar lavage (BAL) was used to gather pulmonary epithelial lining fluid (PELF) and BAL cells.
• The second experiment involved giving minocycline to six horses intragastrically (4 mg/kg, every 12 hours, for five doses). Plasma samples were again taken before and 20 times within 96 hours after administration.
• For this, BAL was performed 6 times within 72 hours after administration for retrieval of PELF samples and BAL cells.
• Based on the results, the average bioavailability of minocycline was calculated to be 48% (ranging from 35% to 75%).

Pharmacokinetics Information

• The maximum concentration (Cmax) of minocycline in plasma at steady state was found to be 2.3 ± 1.3 μg/mL, with a terminal half-life of 11.8 ± 0.5 hours.
• The median time to reach Cmax (Tmax) was 1.3 hours, with an interquartile range (IQR) of 1.0 to 1.5 hours.
• For the PELF, the Cmax and Tmax of minocycline were 10.5 ± 12.8 μg/mL and 9.0 hours respectively, while for BAL cells, they were 0.24 ± 0.1 μg/mL and 6.0 hours.

Conclusions and Clinical Relevance

• The study concluded that minocycline was distributed into the PELF and BAL cells of adult horses. Depending on the method of administration, the time and concentration of maximal absorption varied.
• Overall, these results give key insights for horse health treatment strategies, highlighting the drug’s potential efficiency and reach within the equine body system.